EVALUATION OF PROGNOSTIC MARKERS FOR SURVIVAL IN MDS PATIENTS TREATED WITH AZACITIDINE
A multivariate analysis of the relationship between response and survival among patients with higher-risk myelodysplastic syndromes treated within azacitidine or conventional care regimens in the randomized AZA-001 trial / SD Gore SD, ; Fenaux, P.; Santini, Valeria; Bennett, Jm; Silverman, Lr; Seymour, Jf; Hellström Lindberg, E.; Swern, As; Beach, Cl; List, Af. - In: HAEMATOLOGICA. - ISSN 0390-6078. - STAMPA. - 98:(2013), pp. 1067-1072. [10.3324/haematol.2012.074831]
A multivariate analysis of the relationship between response and survival among patients with higher-risk myelodysplastic syndromes treated within azacitidine or conventional care regimens in the randomized AZA-001 trial.
SANTINI, VALERIA;
2013
Abstract
EVALUATION OF PROGNOSTIC MARKERS FOR SURVIVAL IN MDS PATIENTS TREATED WITH AZACITIDINEFile in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
6716-Article Text-38675-1-10-20200723.pdf
accesso aperto
Descrizione: Articolo
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
1.01 MB
Formato
Adobe PDF
|
1.01 MB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.